University of Texas MD Anderson Cancer Center

Spatial analyses of immune cell infiltration in cancer: current methods and future directions. A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer (2023) Page DB, Broeckx G, Jahangir CA, Verbandt S, Gupta RR, Thagaard J, Khiroya R, et al. Journal article, Review article Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: a report of the international immuno-oncology biomarker working group (2023) Thagaard J, Broeckx G, Page DB, Jahangir CA, Verbandt S, Kos Z, Gupta R, et al. Journal article, Review article A review of a strategic roadmapping exercise to advance clinical translation of photoacoustic imaging: From current barriers to future adoption (2023) Assi H, Cao R, Castelino M, Cox B, Gilbert FJ, Gröhl J, Gurusamy K, et al. Journal article, Review article 25 years International Bladder Cancer Network (IBCN): The past, the present, and the future (2023) Dyrskjøt L, Vlahou A, Black PC, Droller M, Grossmann HB, Goebell P, Kamat AM, et al. Journal article, Review article IgG4-related sclerosing thyroiditis (Riedel-Struma): a review of clinicopathological features and management (2023) Czarnywojtek A, Pietronczyk K, Thompson LDR, Triantafyllou A, Florek E, Sawicka-Gutaj N, Ruchala M, et al. Journal article, Review article Effective treatment of low-risk acute GVHD with itacitinib monotherapy (2023) Etra A, Capellini A, Alousi A, Al Malki MM, Choe H, DeFilipp Z, Hogan WJ, et al. Journal article Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy versus endocrine therapy alone in patients with HR+/HER2− early breast cancer (2023) Slamon DJ, Fasching P, Hurvitz S, Chia S, Crown J, Martín M, Barrios CH, et al. Journal article Bladder preservation after neoadjuvant therapy – 2021 IBCN updates part 1 (2023) Hensley PJ, Seiler R, Herr H, Mouw KW, Iyer G, Dyrskjøt L, Nawroth R, et al. Journal article, Review article A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy (2023) Stein-Thoeringer CK, Saini NY, Zamir E, Blumenberg V, Schubert ML, Mor U, Fante MA, et al. Journal article Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer (2023) Mlecnik B, Lugli A, Bindea G, Marliot F, Bifulco C, Lee JKJ, Zlobec I, et al. Journal article